Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Women's Health News: Breaking Women's Health News, Comments and Articles. - Page: 2

04:21 EDT 23rd April 2014 | BioPortfolio

Women's Health News - Page: 2Twitter RSS

Read the latest Women's Health News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Women's Health.

Search or Follow Our Women's Health - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Women's Health - Page: 2 News.
You can also follow our Women's Health - Page: 2 news stories on Twitter: @womens_womens

Showing "women breast cancer menopause Pregnancy" News Articles 26 to 50 of 22,000+

Tuesday 22nd April 2014

Surefire Medical's Groundbreaking COSY Clinical Trial Results Presented at ECIO: Is Coiling Prior to Radioembolization Still Necessary in Minimally Invasive Treatment of Liver Cancer?

WESTMINSTER, Colo., April 23, 2014 /PRNewswire/ -- Surefire Medical, Inc. announced that a symposium focused on the Coiling vs. Surefire Infusion System in Y90 (COSY) clinical trial will be held during the European Conference on Interventional Oncology (ECIO) meeting taking place in Berlin, Germany April 23-26.   The randomized, prospective radioembolization study showed significant...

Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss The Idiopathic Intracranial Hypertension Treatment Trial

ImportanceAcetazolamide is commonly used to treat idiopathic intracranial hypertension (IIH), but there is insufficient information to establish an evidence base for its use.ObjectiveTo determine whether acetazolamide is beneficial in improving visio...

Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia

JAMA NeurologySerum Brain-Derived Neurotrophic Factor and the Risk for Dementia: The Framingham Heart StudyGalit Weinstein, PhD; Alexa S. Beiser, PhD; Seung Hoan Choi, MS; Sarah R. Preis, ScD, MPH; Tai C. Chen, PhD; Demetrios Vorgas, MSc; Rhoda Au, P...

Oophorectomy Dramatically Reduces Risk of Cancer in BRCA Carriers

For women who carry BRCA1 or BRCA2 mutations, preventive oophorectomy substantially reduced the risk of ovarian, fallopian tube, or peritoneal cancer and all-cause mortality, according to a prospective study of 5783 women followed up for an average o...

Civic Duty Supports Art Show/Fundraiser – Featuring Performance Artist David Garibaldi – for Leukemia Society

Civic Duty, cofounded by Julian Omidi and Dr. Michael Omidi, is donating to the Leukemia & Lymphoma Society’s Man and Woman of the Year campaigns. Those in the Sacramento area are invited to also support this worthy charity by attending a special art auction and show with performance painter David Garibaldi on April 24, 2014, with all proceeds going to help fund new research in hopes of cur...

FDA approves Cyramza to treat patients with advanced stomach cancer

Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standa...

IMPAKT breast cancer conference abstracts online

Xenografts and mathematical modelling; liquid biopsy; nanotechnology; next generation genomics- Science is running fast and the impact of new technologies in the care of patients with breast cancer will be at the core of the sixth edition of the IMPA...

New Roche breast cancer drug unaffordable, says UK body

LONDON, April 23 (Reuters) - A new breast cancer drug from Roche that costs tens of thousands of pounds more than other treatments is unaffordable for Britain's state-run health service, the country's healthcare cost watchdog said on Wednesday.

Trabectedin, a drug acting on both cancer cells and the tumour microenvironment

Tumour-initiating capacity is independent of epithelial–mesenchymal transition status in breast cancer cell lines

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

Breast cancer risk after radiotherapy for heritable and non-heritable retinoblastoma: a US–UK study

Oncogenic KRAS signalling in pancreatic cancer

Can we deliver randomized trials of focal therapy in prostate cancer?

Tissue-preserving focal therapies that target individual cancer lesions rather than the whole prostate have emerged as potential interventions for localized prostate cancer. In this article, the Prostate Cancer RCT Consensus Group recommends the deve...

Tsinghua Creates World’s First In Vitro Tumor Model Using 3D Printing

A research team at Tsinghua University has independently developed 3D printing technology that has produced the world’s first in vitro tumor model of Hela cells (a kind of cervical cancer cell).

Colorectal cancer: Serrated polyposis—should we screen first-degree relatives?

Serrated polyposis syndrome (SPS) is a condition characterized by multiple and/or proximal serrated polyps in the colorectum. Several features of SPS suggest there is an underlying genetic disorder that is yet to be identified. A new study provides i...

Interleukin-21: a double-edged sword with therapeutic potential

The cytokine interleukin-21 (IL-21) regulates immune responses and has potential therapeutic relevance in diseases including cancer, viral infections, autoimmune diseases and allergies. Spolski and Leonard describe our current understanding of IL-21...

Targeting bromodomains: epigenetic readers of lysine acetylation

Inhibiting bromodomains — which are small interaction modules on proteins that assemble acetylation-dependent transcriptional regulatory complexes — could be a way to alter the expression of disease-promoting genes. Here, the authors highlight re...

Taiwan Government Center Joins With Four Firms To Test Cancer Drug

Taiwan's Development Center for Biotechnology said it would contribute $3.31 million to an initial clinical trial in association with four local drug makers to test a drug to treat three types of cancers.

Moran Eye Center Research Team Helps Identify Drug That Restores Sight to Patients with Obesity-Linked Blindness

Glaucoma Drug, Plus Only 5-10 Percent Weight Loss Helps Restore Vision Loss to Patients with Idiopathic Intracranial Hypertension (IIH) National Institutes of Health (NIH)-Funded Study Published in The Journal of the American Medical Association IIH Affects Approximately 100,000 Americans, Predominately Women...

High-fat diets linked to some types of breast cancer

NEW YORK (Reuters Health) - Women who eat a lot of fat, particularly saturated fat, may be at higher risk of certain types of breast cancer, new research suggests.

Killing Cancer on the Run

Read more about Killing Cancer on the RunComments

Cancer patients need anxiety, depression screening

(HealthDay)—It is important to recognize and treat anxiety or depression among cancer patients, according to a clinical guideline published online April 14 in the Journal of Clinical Oncology.

92% Sure: Non-ionizing Cell Phone Radiation Cancer Potential Found in 76 of 80 Studies Peer Reviewed

Scientists find cell phone radiation exposure creates cellular imbalances known to cause cancer in 92% of peer reviewed studies on ROS (Reactive Oxygen Species). RF Safe suggest precautionary measures to reduce excessive RF exposure even at athermic levels. San Francisco, CA (PRWEB) April 22, 2014 According to RF Safe, Scientists confirm non-ionizing cell phone radiation and ionizing UV radiation...

ProNAi Therapeutics brings in $59.5mm through Series D round

Two months after closing a $12mm Series C round, ProNAi Therapeutics Inc. (nucleic acid therapies for cancer) raised $59.5mm through an oversubscribed Series D. Vivo Capital led and was joined by other new investors Frazier Healthcare Ventures, OrbiM...

Search BioPortfolio:

News Quicklinks